The tea polyphenol epigallocatechin-3-O-gallate (EGCG) displays some antidiabetic effects; however the mechanisms are incompletely understood. In the present study, the investigation of the effects of EGCG on insulin resistance was performed in rat L6 cells treated with dexamethasone. We found that dexamethasone increased Ser307 phosphorylation of insulin receptor substrate-1 (IRS-1) and reduced phosphorylation of AMPK and Akt. Furthermore, glucose uptake and glucose transporter (GLUT4) translocation were inhibited by dexamethasone. However, the treatment of EGCG improved insulin-stimulated glucose uptake by increasing GLUT4 translocation to plasma membrane. Furthermore, we also demonstrated these EGCG effects essentially depended on the AM...
Numerous studies propose that epigallocatechin-3-gallate (EGCG), an abundant polyphenol in green tea...
It is known that green tea helps prevent obesity and diabetes mellitus. In this study, we aimed to d...
Metabolic syndrome (MetS) is a clustering of several cardiometabolic risk factors, including abdomin...
Glucose homeostasis is determined by insulin secretion from the ß-cells in pancreatic islets and by ...
Epigallocatechin gallate (EGCG) and L-theanine (LTA) are important bioactive components in tea that ...
In the current investigation, the effect of epigallocatechin gallate (EGCG) on the phosphorylation o...
Epidemiological studies show a dose-dependent relationship between green tea consumption and reduced...
Pancreatic beta cell failure is one critical metabolic disorder in the development of type 2 diabete...
The green tea flavonoid epigallocatechin gallate (EGCG) is one of several compounds that have been r...
Insulin resistance contributes to and precedes the development of type 2 diabetes. Insulin-stimulate...
Obesity and its manifested pathophysiological effects (insulin-resistance, metabolic disease, type 2...
Forkhead/winged helix transcription factor O-class member 1 (FoxO1) is a key mediator of insulin and...
Epigallocatechin gallate (EGCG), a bioactive polyphenol in green tea, may augment metabolic and vasc...
The beneficial effects of green tea polyphenols (GTP) against metabolic syndrome and type 2 diabetes...
HYPOTHESIS: Palmitate causes insulin resistance (IR) in insulin target tissue. Pioglitazone (an anti...
Numerous studies propose that epigallocatechin-3-gallate (EGCG), an abundant polyphenol in green tea...
It is known that green tea helps prevent obesity and diabetes mellitus. In this study, we aimed to d...
Metabolic syndrome (MetS) is a clustering of several cardiometabolic risk factors, including abdomin...
Glucose homeostasis is determined by insulin secretion from the ß-cells in pancreatic islets and by ...
Epigallocatechin gallate (EGCG) and L-theanine (LTA) are important bioactive components in tea that ...
In the current investigation, the effect of epigallocatechin gallate (EGCG) on the phosphorylation o...
Epidemiological studies show a dose-dependent relationship between green tea consumption and reduced...
Pancreatic beta cell failure is one critical metabolic disorder in the development of type 2 diabete...
The green tea flavonoid epigallocatechin gallate (EGCG) is one of several compounds that have been r...
Insulin resistance contributes to and precedes the development of type 2 diabetes. Insulin-stimulate...
Obesity and its manifested pathophysiological effects (insulin-resistance, metabolic disease, type 2...
Forkhead/winged helix transcription factor O-class member 1 (FoxO1) is a key mediator of insulin and...
Epigallocatechin gallate (EGCG), a bioactive polyphenol in green tea, may augment metabolic and vasc...
The beneficial effects of green tea polyphenols (GTP) against metabolic syndrome and type 2 diabetes...
HYPOTHESIS: Palmitate causes insulin resistance (IR) in insulin target tissue. Pioglitazone (an anti...
Numerous studies propose that epigallocatechin-3-gallate (EGCG), an abundant polyphenol in green tea...
It is known that green tea helps prevent obesity and diabetes mellitus. In this study, we aimed to d...
Metabolic syndrome (MetS) is a clustering of several cardiometabolic risk factors, including abdomin...